Peggy Sotiropoulou

Dr. Peggy Sotiropoulou is the CSO of T-knife Therapeutics. She is a biotech leader with 25+ years advancing immuno-oncology and cell therapy programs from discovery to clinic. As CSO at T-knife Therapeutics, she leads the development of Supercharged T cell therapies for patients with solid tumors. Formerly Head of R&D at Celyad Oncology, Peggy developed scalable engineered CAR T cell therapy platforms. Prior to that, Peggy was tenured Associate Professor at Université Libre de Bruxelles, leading research on the response and sensitization of recalcitrant tumors to therapy. Peggy holds a PhD in Cancer Immunology from the University of Crete and an MSc in Biological Sciences from the University of Athens.